Related references
Note: Only part of the references are listed.Linear Regression Equations To Predict β-Lactam, Macrolide, Lincosamide, and Fluoroquinolone MICs from Molecular Antimicrobial Resistance Determinants in Streptococcus pneumoniae
Walter Demczuk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Miwako Kobayashi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Invasive Pneumococcal Disease: Concerning Trends in Serotype 19A Notifications in New Zealand
Andrew Anglemyer et al.
CLINICAL INFECTIOUS DISEASES (2022)
Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium
Stefanie Desmet et al.
EMERGING INFECTIOUS DISEASES (2022)
Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
Stefanie Desmet et al.
LANCET INFECTIOUS DISEASES (2021)
Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018
Alyssa R. Golden et al.
VACCINE (2021)
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15
Alyssa R. Golden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness
I. Yildirim et al.
VACCINE (2017)
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13
Alyssa R. Golden et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children
Mark van der Linden et al.
BMC INFECTIOUS DISEASES (2013)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012
Walter H. B. Demczuk et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2013)
Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199
Maria Del Grosso et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine
Filippo Ansaldi et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Shifting Genetic Structure of Invasive Serotype 19A Pneumococci in the United States
Bernard W. Beall et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007
Julie A. Bettinger et al.
VACCINE (2010)
Vaccine escape recombinants emerge after pneumococcal vaccination in the united states
Angela B. Brueggemann et al.
PLOS PATHOGENS (2007)